Nadir bir ARDS nedeni: akciğer tutulumu yapan hipereozinofilik sendrom

Objective & Hypothesis:Idiopathic hypereosinophilic syndrome (HES) is a rare disorder of unknown etiology characterized by eosinophilia of at least six-months duration and organ involvement due to eosinophilia.

📊

Key Findings & Data:Moreover, at the beginning of the case of HES, presenting with ARDS is rarely seen.

💡

Conclusion & Impact:We present our case according to those uncommon features. (JAEM 2013; 12: 105-8)

🔬Design:Research Article

📍Scope:2013 Verileri

⚙️Variables:Domain Parameters

Abstract

Idiopathic hypereosinophilic syndrome (HES) is a rare disorder of unknown etiology characterized by eosinophilia of at least six-months duration and organ involvement due to eosinophilia. Moreover, at the beginning of the case of HES, presenting with ARDS is rarely seen. We present our case according to those uncommon features. (JAEM 2013; 12: 105-8)

Özet

İdyopatik hipereozinofilik sendrom (HES), altı aydan uzun süreli hipereozinofili ve eozinofiliye bağlı çeşitli organ tutulumları ile karakterli, etiyolojisi bilinmeyen nadir bir hastalıktır. Ayrıca, HES tanısı konulan bir olgumuzda olduğu gibi klinik tablonun ARDS ile başlaması da sık rastlanmayan bir durumdur. Bu nedenlerle olgumuzu sunmayı uygun bulduk. (JAEM 2013; 12: 105-8)

🔖

Cite This Article

SUNGURTEKİN, H., SERİN, S., KITER, G., TEKELİOĞLU, Ü. Y. (2022). Nadir bir ARDS nedeni: akciğer tutulumu yapan hipereozinofilik sendrom. Akademik Acil Tıp Dergisi, Cilt: 12 - Sayı: 2, 105–108. https://ajindex.com/articles/430312

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (6)

Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 2002; 359: 1577-8. [CrossRef ] Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759-79.
Ackerman SJ, Butterfield JH. Eosinophilia, eosinophil and the hypereosi- nophilic syndrome. Hematology. Basic Principles and Practice. New York: Churchill Livingstone; 2000.p. 702-20.
Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. Idi- opatic hypereosinophilic syndrome: clinical, pathophysiologic, and thera- peutic considerations. Ann Intern Med 1982; 97: 78-92.
Polat SK, Avcı E, Polat G, Aşuk Z, İnce S, Yücel N, ve ark. Metastatik akciğer tümörünü taklit eden idiyopatik hipereozinofili sendrom olgusu. Solu- num 2006; 8: 119-23.
De Vriese AS, Kips JC, Vogelaers DP, Vandewoude KH, Cuvelier CA, Colard- yn FA. Pitfalls in the diagnosis of hypereosinophilic syndrome: a report of two cases. J Intern Med 1997; 241: 165-70. [CrossRef ] Spry CJ. The hypereosinophilic syndrome: Clinical features, laboratory fin- dings and treatment. Allergy 1982; 37: 539-51. [CrossRef] Kang E, Shim JJ, Kim SS, Kim K. Pulmonary involvement of idiopathic hy- pereosinophilic syndrome: CT findings in five patients. J Comput Assist Tomogr 1997; 21: 612-5. [CrossRef] Winn RE, Kollef MH, Meyer JI. Pulmonary involvement in the hypereosi- nophilic syndrome. Chest 1994; 105: 656-60. [CrossRef ] Gökırmak M, Hasanoğlu C, Aydoğdu İ, Köksal N, Yıldırım Z, Tuncer C. Ek- suda niteliğinde plevra sıvısıyla ortaya çıkan bir hipereozinofilik sendrom olgusu. Solunum 2000; 2: 108-11.
Butterfield JH, Gleich GJ. Response of six patients with idiopathic hypere- osinophilic syndrome to interferon alfa. J Allergy Clin Immunol 1994; 94: 1318-26. [CrossRef ] Esteva-Lorenzo FJ, Meehan KR, Spitzer TR, Mazumder A. Allogeneic bone marrow transplantation in a patient with hypereosinophilic syndrome. Am J Hematol 1996; 51: 164-5. [CrossRef ]